US Nuclear Corp Reports Significant Growth in Overhoff Technology Segment
US Nuclear Corp (OTC: UCLE) has announced a remarkable 55% surge in Overhoff Technology’s gross profit, reaching nearly $1.2 million on revenues exceeding $2 million,...
Aristocrat Group Corporation Secures Exclusive Licensing Agreement with Merica Beer
Aristocrat Group Corporation (OTC: ASCC) has entered into a strategic licensing agreement with Merica Beer, a brand celebrated for its American identity and consumer appeal,...
BlueSky AI Inc. Strengthens AI Infrastructure Market with SkyMod Data Centers
BlueSky AI Inc. (OTC: BSAI) has made significant strides in the AI infrastructure market with the launch of its SkyMod modular data centers. These prefabricated...
Nutriband Inc. Advances in Opioid Safety with AVERSA(TM) Fentanyl Milestone
Nutriband Inc. (NASDAQ: NTRB) has recently completed commercial-scale manufacturing for AVERSA(TM) Fentanyl, a pivotal step toward FDA approval, in collaboration with Kindeva Drug Delivery. This...
Metavesco Completes Significant Share Buyback to Enhance Shareholder Value
Metavesco, Inc. (OTC: MVCO), a diversified holding company, has announced the completion of a buyback of 200 million shares of its common stock, marking a...
Goliath Resources Reports Significant Gold Findings at Golddigger Property, Expands 2025 Drill Program
Goliath Resources Limited, a portfolio company of McEwen Mining Inc., has announced the discovery of six new visible gold occurrences within a 96.5-meter mineralized interval...
Tonix Pharmaceuticals’ TNX-1700 Shows Promise in Enhancing Immunotherapy for Gastric Cancer
Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) has recently published preclinical data in Cancer Cells that highlights the potential of its fusion protein candidate, mTNX-1700, to...
Nightfood Holdings Inc. (NGTF) Pioneers AI and Robotics in Hospitality Sector
Nightfood Holdings Inc. (OTCQB: NGTF) is making significant strides in the hospitality sector by integrating artificial intelligence and robotics to address labor shortages and enhance...
Oragenics Inc. Secures $16.5 Million to Advance Intranasal Concussion Therapy
Oragenics Inc. (NYSE American: OGEN), a clinical-stage biotechnology company, has successfully closed a public offering of Series H Convertible Preferred Stock and Warrants, amassing approximately...